🇺🇸 FDA
Pipeline program

-aminosalicylic acid

199/12012

Phase 2 small_molecule completed

Quick answer

-aminosalicylic acid for Ulcerative Colitis is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Ulcerative Colitis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials